Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans
Phase 1
Completed
- Conditions
- Treatment of Acute Yellow Fever Virus Infection
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2019-10-25
- Lead Sponsor
- Tysana Pte Ltd
- Target Recruit Count
- 37
- Registration Number
- NCT03776786
- Locations
- 🇸🇬
SingHealth Investigational Medicine Unit, Singapore, Singapore
News
No news found